Literature DB >> 16686591

The epidemiology and diagnosis of insomnia.

Karl Doghramji1.   

Abstract

Many questions remain unanswered with regard to our understanding of insomnia. Although it is generally believed that 10% to 15% of the adult population suffers from chronic insomnia, and an additional 25% to 35% have transient or occasional insomnia, prevalence estimates vary because of inconsistent definitions and diagnostic criteria. The elderly in particular are affected by insomnia, and it has been shown that women are more likely to have sleep difficulties than men. Although insomnia can be a primary condition, and can coexist with other disorders or be considered secondary to these disorders, the mechanisms producing it are not clearly defined. Additionally, the relationship between insomnia and other disease states is not always clear because it is often not possible to determine the cause-and-effect relationship between disorders. Epidemiologic studies show that abnormal sleep patterns predict lower life expectancy, and that people with insomnia are more likely to develop affective disorders, substance abuse, and other adverse health outcomes. This article will provide an overview of insomnia, its prevalence and epidemiology, and guidelines for clinical assessment.

Entities:  

Mesh:

Year:  2006        PMID: 16686591

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  39 in total

Review 1.  Acupuncture for treatment of insomnia: a systematic review of randomized controlled trials.

Authors:  Huijuan Cao; Xingfang Pan; Hua Li; Jianping Liu
Journal:  J Altern Complement Med       Date:  2009-11       Impact factor: 2.579

2.  Predictors of outcome for telephone and face-to-face administered cognitive behavioral therapy for depression.

Authors:  C Stiles-Shields; M E Corden; M J Kwasny; S M Schueller; D C Mohr
Journal:  Psychol Med       Date:  2015-06-16       Impact factor: 7.723

Review 3.  Low-dose doxepin: in the treatment of insomnia.

Authors:  Juliane Weber; M Asif A Siddiqui; Antona J Wagstaff; Paul L McCormack
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 4.  Economic implications of sleep disorders.

Authors:  Tracy L Skaer; David A Sclar
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Pharmacokinetics of a Novel Zolpidem Nasal Spray for Rapid Management of Insomnia: First Trial in Humans.

Authors:  Cheng-Tai Li; Tung-Ping Su; Yanfeng Wang; Benjamin Lee; Melvin Toh; Tony Ho
Journal:  J Clin Sleep Med       Date:  2016-11-15       Impact factor: 4.062

6.  Trajectories of cigarette smoking in adulthood predict insomnia among women in late mid-life.

Authors:  David W Brook; Elizabeth Rubenstone; Chenshu Zhang; Judith S Brook
Journal:  Sleep Med       Date:  2012-08-15       Impact factor: 3.492

7.  Validity and reliability of the Iranian version of the insomnia severity index.

Authors:  Zohreh Yazdi; Khosro Sadeghniiat-Haghighi; Mohammad Ali Zohal; Khadijeh Elmizadeh
Journal:  Malays J Med Sci       Date:  2012-10

8.  Physiotherapy for sleep disturbance in chronic low back pain: a feasibility randomised controlled trial.

Authors:  Deirdre A Hurley; Jennifer Eadie; Grainne O'Donoghue; Clare Kelly; Chris Lonsdale; Suzanne Guerin; Mark A Tully; Willem van Mechelen; Suzanne M McDonough; Colin A G Boreham; Conor Heneghan; Leslie Daly
Journal:  BMC Musculoskelet Disord       Date:  2010-04-16       Impact factor: 2.362

Review 9.  Ramelteon: a review of its use in insomnia.

Authors:  Dene Simpson; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression.

Authors:  Ellen Snyder; Bing Cai; Carla DeMuro; Mary F Morrison; William Ball
Journal:  J Clin Sleep Med       Date:  2018-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.